Preclinical Drug Development
Advancing Science with Expertise in Preclinical Drug Development
At Lovelace Biomedical, we understand that successful preclinical drug development is the foundation of every life-saving therapy. As an established leader in translational science, we specialize in offering comprehensive preclinical solutions that support the advancement of innovative drug candidates from discovery to clinical trials. Whether you're a biotech startup or a pharmaceutical industry leader, our expertise, state-of-the-art facilities, and regulatory insight ensure your preclinical program meets the highest standards.
Comprehensive Preclinical Drug Development Services
Our full-service preclinical drug development program includes everything you need to navigate the early stages of drug research. From pharmacokinetics and toxicology to efficacy and bioanalytical support, we deliver high-quality data designed to meet global regulatory requirements. Lovelace Biomedical offers customized study design and flexible timelines to help accelerate your path to the clinic without compromising on quality or compliance. With over 70 years of experience, we’ve earned our reputation by helping clients confidently move through the preclinical drug development process. Our team works closely with you to develop robust, science-driven studies that minimize risk and deliver clear, actionable results.
Innovative Technology Driving Preclinical Drug Development
Lovelace Biomedical harnesses cutting-edge technology to streamline and enhance the preclinical drug development process. Our facilities include advanced imaging equipment, secure bioanalysis labs, and dedicated toxicology units. This infrastructure enables us to conduct a broad range of preclinical studies, including GLP and non-GLP toxicology, pharmacokinetics, ADME, and more. By integrating innovative technology into every stage of preclinical drug development, we improve study accuracy, reduce turnaround times, and optimize data integrity. Our scientific team remains on the forefront of evolving methodologies, ensuring that your program benefits from the latest advancements in biomedical research.
Regulatory-Ready Preclinical Drug Development Studies
Navigating the regulatory landscape can be one of the most challenging aspects of preclinical drug development. Our experienced regulatory team ensures that all studies meet FDA, EMA, and ICH guidelines. With Lovelace Biomedical, you can be confident that your data will be defensible, reproducible, and aligned with industry expectations. Our strength lies not only in our scientific rigor but also in our dedication to personalized service. We’re not just a contract research organization—we’re an extension of your team. When you work with us, you’re gaining a trusted partner that is fully invested in the success of your preclinical drug development program. Whether you’re preparing for an IND submission or building a foundation for a first-in-human study, our preclinical drug development expertise can help you anticipate and address regulatory requirements early in the process.
Partner with Lovelace Biomedical for Preclinical Drug Development
If you’re ready to advance your therapeutic through the preclinical drug development process, Lovelace Biomedical is here to help. Our team offers the scientific excellence, regulatory know-how, and collaborative spirit to bring your drug discovery efforts to life. Contact us today to learn how we can support your journey from preclinical to clinical success. Reach out to our Business Development office to get started and advance your preclinical drug development goals.
Get Started Today with Preclinical Contract Research at Lovelace Biomedical
Ready to elevate your development pipeline? Contact Lovelace Biomedical to learn more about our world-class preclinical contract research capabilities. Let us help you turn scientific potential into regulatory success. Reach out to our Business Development office to learn more about our preclinical contract research solutions.